The Li lab is currently working to reconcile an enduring intellectual disconnect concerning BRCA1-associated cancer, elevate ERĪ² signaling to significantly boost current anticancer therapies, and enhance therapeutic efficacy of cancer treatment by targeting newly discovered signaling pathways involved in adipose-immune-tumor crosstalk.
Research
Explore the Li Lab's research with its focus on BRCA1-associated cancer.
Publications
See a list of publications from Dr. Li.